Does the media favor AVR or PROF?

In the previous week, Anteris Technologies Global had 9 more articles in the media than Profound Medical. MarketBeat recorded 10 mentions for Anteris Technologies Global and 1 mentions for Profound Medical. Anteris Technologies Global's average media sentiment score of 0.74 beat Profound Medical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, PROF or INMD?

InMode has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Profound Medical $16.10M 14.83 -$42.57M -$1.24 N/A InMode $370.49M 2.31 $93.83M $1.36 9.93

Is PROF or INMD more profitable?

InMode has a net margin of 23.27% compared to Profound Medical's net margin of -206.76%. InMode's return on equity of 13.47% beat Profound Medical's return on equity. Company Net Margins Return on Equity Return on Assets Profound Medical -206.76% -78.88% -64.06% InMode 23.27% 13.47% 11.95%

Does the media refer more to PROF or INMD?

In the previous week, InMode had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for InMode and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.00 equaled InMode'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PROF or DRTS?

In the previous week, Alpha Tau Medical had 7 more articles in the media than Profound Medical. MarketBeat recorded 8 mentions for Alpha Tau Medical and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.00 beat Alpha Tau Medical's score of -0.31 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Tau Medical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media favor SSII or PROF?

In the previous week, SS Innovations International had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for SS Innovations International and 1 mentions for Profound Medical. SS Innovations International's average media sentiment score of 0.33 beat Profound Medical's score of 0.00 indicating that SS Innovations International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, PROF or BVS?

Bioventus has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Profound Medical $16.10M 14.83 -$42.57M -$1.24 N/A Bioventus $568.09M 1.32 $22.73M $0.41 21.83

Does the media refer more to PROF or BVS?

In the previous week, Bioventus had 3 more articles in the media than Profound Medical. MarketBeat recorded 4 mentions for Bioventus and 1 mentions for Profound Medical. Bioventus' average media sentiment score of 0.09 beat Profound Medical's score of 0.00 indicating that Bioventus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bioventus 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Profound Medical (PROF) Competitors

$6.57 -0.09 (-1.35%)

Closing price 06/8/2026 04:00 PM Eastern

Extended Trading

$6.57 0.00 (0.00%)

As of 06/8/2026 04:10 PM Eastern

Compare

PROF vs. AVR, INMD, DRTS, SSII, and BVS

Should you buy Profound Medical stock or one of its competitors? MarketBeat compares Profound Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Profound Medical include Anteris Technologies Global (AVR), InMode (INMD), Alpha Tau Medical (DRTS), SS Innovations International (SSII), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

How does Profound Medical compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

47.9% of Profound Medical shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Anteris Technologies Global currently has a consensus price target of $16.00, indicating a potential upside of 71.31%. Profound Medical has a consensus price target of $12.00, indicating a potential upside of 82.65%. Given Profound Medical's higher probable upside, analysts plainly believe Profound Medical is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Anteris Technologies Global has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

In the previous week, Anteris Technologies Global had 9 more articles in the media than Profound Medical. MarketBeat recorded 10 mentions for Anteris Technologies Global and 1 mentions for Profound Medical. Anteris Technologies Global's average media sentiment score of 0.74 beat Profound Medical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Profound Medical has higher revenue and earnings than Anteris Technologies Global. Profound Medical is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	476.00	-$94.14M	-$2.23	N/A
Profound Medical	$16.10M	14.83	-$42.57M	-$1.24	N/A

Profound Medical has a net margin of -206.76% compared to Anteris Technologies Global's net margin of -5,148.78%. Profound Medical's return on equity of -78.88% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Profound Medical	-206.76%	-78.88%	-64.06%

Summary

Anteris Technologies Global and Profound Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Profound Medical compare to InMode?

Profound Medical (NASDAQ:PROF) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

InMode has a net margin of 23.27% compared to Profound Medical's net margin of -206.76%. InMode's return on equity of 13.47% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
InMode	23.27%	13.47%	11.95%

Profound Medical presently has a consensus price target of $12.00, indicating a potential upside of 82.65%. InMode has a consensus price target of $16.00, indicating a potential upside of 18.52%. Given Profound Medical's higher possible upside, equities analysts plainly believe Profound Medical is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Profound Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, InMode has a beta of 1.94, suggesting that its stock price is 94% more volatile than the broader market.

InMode has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	14.83	-$42.57M	-$1.24	N/A
InMode	$370.49M	2.31	$93.83M	$1.36	9.93

In the previous week, InMode had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for InMode and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.00 equaled InMode'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

InMode beats Profound Medical on 11 of the 13 factors compared between the two stocks.

How does Profound Medical compare to Alpha Tau Medical?

Profound Medical (NASDAQ:PROF) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Profound Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Profound Medical currently has a consensus price target of $12.00, suggesting a potential upside of 82.65%. Alpha Tau Medical has a consensus price target of $12.60, suggesting a potential upside of 35.78%. Given Profound Medical's higher possible upside, equities research analysts plainly believe Profound Medical is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Alpha Tau Medical has a net margin of 0.00% compared to Profound Medical's net margin of -206.76%. Alpha Tau Medical's return on equity of -73.23% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
Alpha Tau Medical	N/A	-73.23%	-52.90%

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profound Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	14.83	-$42.57M	-$1.24	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

In the previous week, Alpha Tau Medical had 7 more articles in the media than Profound Medical. MarketBeat recorded 8 mentions for Alpha Tau Medical and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.00 beat Alpha Tau Medical's score of -0.31 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Tau Medical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Alpha Tau Medical beats Profound Medical on 9 of the 15 factors compared between the two stocks.

How does Profound Medical compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and Profound Medical (NASDAQ:PROF) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

In the previous week, SS Innovations International had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for SS Innovations International and 1 mentions for Profound Medical. SS Innovations International's average media sentiment score of 0.33 beat Profound Medical's score of 0.00 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SS Innovations International has higher revenue and earnings than Profound Medical. SS Innovations International is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	16.63	-$12.13M	-$0.05	N/A
Profound Medical	$16.10M	14.83	-$42.57M	-$1.24	N/A

SS Innovations International currently has a consensus target price of $7.00, indicating a potential upside of 98.30%. Profound Medical has a consensus target price of $12.00, indicating a potential upside of 82.65%. Given SS Innovations International's higher probable upside, equities analysts plainly believe SS Innovations International is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SS Innovations International has a net margin of -20.69% compared to Profound Medical's net margin of -206.76%. SS Innovations International's return on equity of -23.00% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
Profound Medical	-206.76%	-78.88%	-64.06%

SS Innovations International has a beta of -1.89, meaning that its stock price is 289% less volatile than the broader market. Comparatively, Profound Medical has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

Summary

SS Innovations International beats Profound Medical on 10 of the 16 factors compared between the two stocks.

How does Profound Medical compare to Bioventus?

Profound Medical (NASDAQ:PROF) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

In the previous week, Bioventus had 3 more articles in the media than Profound Medical. MarketBeat recorded 4 mentions for Bioventus and 1 mentions for Profound Medical. Bioventus' average media sentiment score of 0.09 beat Profound Medical's score of 0.00 indicating that Bioventus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bioventus	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bioventus has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	14.83	-$42.57M	-$1.24	N/A
Bioventus	$568.09M	1.32	$22.73M	$0.41	21.83

Profound Medical currently has a consensus price target of $12.00, suggesting a potential upside of 82.65%. Bioventus has a consensus price target of $14.00, suggesting a potential upside of 56.42%. Given Profound Medical's higher probable upside, equities research analysts plainly believe Profound Medical is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Profound Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Bioventus has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Bioventus has a net margin of 4.94% compared to Profound Medical's net margin of -206.76%. Bioventus' return on equity of 29.97% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
Bioventus	4.94%	29.97%	9.52%

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Bioventus beats Profound Medical on 14 of the 17 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PROF vs. The Competition

Export

Metric	Profound Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$242.01M	$2.96B	$6.48B	$11.99B
Dividend Yield	N/A	1.70%	2.67%	5.58%
P/E Ratio	-5.30	17.68	23.69	23.74
Price / Sales	14.83	302.68	514.83	109.27
Price / Cash	N/A	56.17	26.99	37.25
Price / Book	3.59	3.83	10.43	6.78
Net Income	-$42.57M	$75.85M	$3.57B	$337.51M
7 Day Performance	1.39%	-2.00%	0.27%	-2.34%
1 Month Performance	-4.09%	-5.85%	3.25%	1.88%
1 Year Performance	14.26%	14.03%	22.24%	25.55%

Profound Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PROF Profound Medical	1.6401 of 5 stars	$6.57 -1.4%	$12.00 +82.6%	+18.0%	$242.01M	$16.10M	N/A	150
AVR Anteris Technologies Global	3.9582 of 5 stars	$9.29 +2.1%	$16.00 +72.2%	+97.0%	$904.29M	$1.91M	N/A	138	News Coverage
INMD InMode	2.0904 of 5 stars	$13.50 -0.7%	$16.00 +18.5%	-4.7%	$855.36M	$370.49M	9.93	480	Positive News
DRTS Alpha Tau Medical	3.2654 of 5 stars	$8.93 -7.6%	$12.20 +36.6%	+207.3%	$806.65M	N/A	N/A	80	High Trading Volume
SSII SS Innovations International	1.908 of 5 stars	$4.01 +1.8%	N/A	-41.2%	$802.53M	$48.47M	N/A	4	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PROF) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Profound Medical (PROF) Competitors

PROF vs. AVR, INMD, DRTS, SSII, and BVS

How does Profound Medical compare to Anteris Technologies Global?

Summary

How does Profound Medical compare to InMode?

Summary

How does Profound Medical compare to Alpha Tau Medical?

Summary

How does Profound Medical compare to SS Innovations International?

Summary

How does Profound Medical compare to Bioventus?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PROF vs. The Competition

Profound Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Profound Medical (PROF) Competitors

PROF vs. AVR, INMD, DRTS, SSII, and BVS

How does Profound Medical compare to Anteris Technologies Global?

Do institutionals and insiders have more ownership in AVR or PROF?

Do analysts prefer AVR or PROF?

Which has more volatility and risk, AVR or PROF?

Does the media favor AVR or PROF?

Which has stronger valuation and earnings, AVR or PROF?

Is AVR or PROF more profitable?

Summary

How does Profound Medical compare to InMode?

Do insiders and institutionals believe in PROF or INMD?

Is PROF or INMD more profitable?

Do analysts recommend PROF or INMD?

Which has more volatility & risk, PROF or INMD?

Which has better valuation and earnings, PROF or INMD?

Does the media refer more to PROF or INMD?

Summary

How does Profound Medical compare to Alpha Tau Medical?

Which has more risk & volatility, PROF or DRTS?

Do analysts recommend PROF or DRTS?

Is PROF or DRTS more profitable?

Do institutionals and insiders have more ownership in PROF or DRTS?

Which has preferable valuation and earnings, PROF or DRTS?

Does the media prefer PROF or DRTS?

Summary

How does Profound Medical compare to SS Innovations International?

Does the media favor SSII or PROF?

Which has higher earnings & valuation, SSII or PROF?

Do analysts prefer SSII or PROF?

Do institutionals & insiders believe in SSII or PROF?

Is SSII or PROF more profitable?

Which has more volatility & risk, SSII or PROF?

Summary

How does Profound Medical compare to Bioventus?

Does the media refer more to PROF or BVS?

Which has stronger valuation and earnings, PROF or BVS?

Do analysts prefer PROF or BVS?

Which has more volatility and risk, PROF or BVS?

Is PROF or BVS more profitable?

Do institutionals and insiders hold more shares of PROF or BVS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PROF vs. The Competition

Profound Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools